Group One Trading
CYCN icon

Group One Trading’s Cyclerion Therapeutics CYCN Stock Holding History

Group One Trading’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45
Closed -$1K – 7939
2022
Q1 		$1K Sell
45
-320
-88% -$7.71K ﹤0.01% 7819
2021
Q4 		$13K Sell
365
-1,855
-84% -$87.6K ﹤0.01% 7218
2021
Q3 		$136K Buy
2,220
+535
+32% +$35K ﹤0.01% 5584
2021
Q2 		$131K Buy
+1,685
New +$106K ﹤0.01% 5684
2021
Q1 		– Sell
-250
Closed -$15K – 7646
2020
Q4 		$15K Buy
+250
New +$17K ﹤0.01% 5637

Other funds holding CYCN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Group One Trading's CYCN Position: Q1 2026 in Review

Group One Trading held its Cyclerion Therapeutics (CYCN) position steady in Q1 2026 at 192 shares worth $295. The position accounts for ﹤0.01% of the portfolio, ranked #7370.

Group One Trading first reported a position in CYCN in Q1 2020 and has held it in 25 quarters since. The position peaked at $104K in Q3 2021. 17 funds tracked by Wall St. Rank hold CYCN as of Q1 2026.

  • Group One Trading held 192 shares of Cyclerion Therapeutics worth $295 as of Q1 2026.
  • Group One Trading left its Cyclerion Therapeutics share count unchanged in Q1 2026.
  • Cyclerion Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7370 holding.
  • Group One Trading first reported a position in Cyclerion Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Group One Trading's Cyclerion Therapeutics position peaked at $104K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.